Executive Intelligence

Jacob Donoghue

Founder

Jacob Donoghue is listed as a founder of Beacon Biosignals on the Brel Digital company profile. Expand biography only from verified public sources.

Quick Facts

Role Founder
Company Beacon Biosignals
Country United States
Industry AI in Healthcare
Founded 2019
Known For Beacon Biosignals upsized its Series B to over $97 million in April 2026 — capital aimed…
Status Active
Last Reviewed Aug 2026

Jacob Donoghue is listed as a founder of Beacon Biosignals on the Brel Digital company profile. Expand biography only from verified public sources.

Verified company milestones linked to this executive’s organization.

2019 Company founded
Beacon Biosignals was founded in 2019 per the company profile source on file.
Source
2019 Leadership
2019: Beacon Biosignals founded in Boston; Jacob Donoghue, MD, PhD, is CEO and co-founder.
Source
2025 Acquisition
April 21, 2025: Beacon completed acquisition of CleveMed, expanding home sleep testing capabilities.
Source
2026 Funding
April 6, 2026: Beacon announced Series B extension bringing round total to $97 million and cumulative funding to over $132 million.
Source

View Company Official Website

Biotechnology

Beacon Platform combining FDA-cleared wearable EEG (Waveband, formerly Dreem 3S) with AI analytics for sleep, neurology,…

View Product

Jacob Donoghue is listed as a founder of Beacon Biosignals on the Brel Digital company profile. Expand biography only from verified public sources.

Request a correction if you represent this company or believe information is inaccurate.

Founder and company intelligence, weekly.